Super-refractory Status Epilepticus
📧 Sign up to get email alerts when something new happens for Super-refractory Status Epilepticus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
A multicenter retrospective study assessing isoflurane for refractory and super-refractory status epilepticus; the trial has completed.
-
CLINICAL_TRIALS withdrawal · 2025-09-15Clinical Trial Update: An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
An open-label expanded-access trial of SAGE-547 for Super-Refractory Status Epilepticus is no longer available.
-
CLINICAL_TRIALS trial_result · 2022-05-03Clinical Trial Update: Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus [Phase 1, Phase 2]
This clinical trial update reports that the Phase 1/2 study evaluating SAGE-547 as adjunctive therapy for super-refractory status epilepticu…
-
CLINICAL_TRIALS trial_result · 2019-05-02Clinical Trial Update: A Study With SAGE-547 for Super-Refractory Status Epilepticus [Phase 3]
Phase 3 study of SAGE-547 (ganaxolone) for super-refractory status epilepticus has completed, with results posted in May 2019.